BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 29, 2007
View Archived Issues
Omrix's Shares Climb After Evithrom Wins FDA Approval
The FDA gave its nod of approval to Omrix Biopharmaceutical Inc.'s Evithrom, the first standalone human thrombin product approved since 1954 and the only such product with U.S. licensing. (BioWorld Today)
Read More
FDA Sets New PDUFA Date For Adolor's Entereg In POI
Read More
XOMA Gets $30 Million Upfront In Pfizer Technology Deal
Read More
Indevus Files For FDA Approval For Long-Acting Testosterone
Read More
Other News To Note
Read More
Clinic Roundup
Read More